Target | cis/trans | Study | SNP | SNP location | Maj/min allele | MAF | N | βinv | seinv | Pinv | fclog | Plog | Praw |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
GRN | trans | Discovery | rs646776 | 1:109,818,530 | T/C | 0.22 | 996 | -0.758 | 0.047 | 1×10-52 | -1.120 | 2.3×10-52 | 2.4×10-47 |
GRN | trans | Replication | rs646776 | 1:109,818,530 | A/G | 0.20 | 337 | -0.674 | 0.072 | 1.7×10-18 | -1.150 | 9.7×10-15 | 1.2×10-11 |
Catalase | trans | Discovery | rs646776 | 1:109,818,530 | T/C | 0.22 | 996 | -0.336 | 0.049 | 1.5×10-11 | -1.090 | 6.8×10-10 | 5.1×10-7 |
Catalase | trans | Replication | rs660240 | 1:109,817,838 | G/A | 0.20 | 337 | -0.057 | 0.089 | 0.527 | -1.010 | 0.702 | 0.924 |
RGMA | trans | Discovery | rs646776 | 1:109,818,530 | T/C | 0.22 | 996 | -0.324 | 0.052 | 5.1×10-10 | -1.060 | 1.3×10-9 | 7.8×10-9 |
RGMA | trans | Replication | rs629301 | 1:109,818,306 | A/C | 0.20 | 337 | -0.155 | 0.067 | 0.022 | -1.040 | 0.048 | 0.024 |
Target (abbrv.) | GRN |
Target (full name) | Granulins |
Somalogic ID (Sequence ID) | SL007173 (4992-49_1) |
Entrez Gene Symbol | GRN |
UniProt ID | P28799 |
UniProt Comment |
|
Wiki Pathways |
|
Target (abbrv.) | Catalase |
Target (full name) | Catalase |
Somalogic ID (Sequence ID) | SL000342 (3488-64_2) |
Entrez Gene Symbol | CAT |
UniProt ID | P04040 |
UniProt Comment |
|
Targeted by drugs (based on IPA annotation) |
|
Biomarker applications (based on IPA annotation) |
|
Wiki Pathways |
|
Pathway Interaction Database |
|
Reactome |
|
Pathway Studio |
|
Target (abbrv.) | RGMA |
Target (full name) | Repulsive guidance molecule A |
Somalogic ID (Sequence ID) | SL010467 (3833-10_2) |
Entrez Gene Symbol | RGMA |
UniProt ID | Q96B86 |
UniProt Comment |
|
All locus annotations are based on the sentinel SNP (rs646776) and 9 proxy variant(s) that is/are in linkage disequilibrium r2 ≥ 0.8. Linkage disequilibrium is based on data from the 1000 Genomes Project, phase 3 version 5, European population and was retrieved using SNiPA's Block Annotation feature.
Download the detailed results of SNiPA's block annotation (PDF)
Genes hit or close-by | |
Potentially regulated genes |
|
eQTL genes |
Trait | P | Study | Source |
---|---|---|---|
SORT1 gene expression in human liver | 2×10-300 | 20686565 (PMID) | GRASP2 nonQTL |
LDL cholesterol | 1.6×10-272 | 24097068 (PMID) | Supplemental file |
PSRC1 gene expression in human liver | 2×10-271 | 20686565 (PMID) | GRASP2 nonQTL |
Gene expression of SORT1 in Liver | 3.8×10-227 | 21378990 (PMID) | GRASP2 nonQTL |
Gene expression of PSRC1 in Liver | 1.4×10-193 | 21378990 (PMID) | GRASP2 nonQTL |
Triglycerides | 4.8×10-187 | 24097068 (PMID) | Supplemental file |
Cholesterol, total | 2×10-170 | 24097068 (PMID) | GWAS Catalog via SNiPA |
Gene expression of reporter ID 10026392691 in liver | 7.2×10-140 | 20084173 (PMID) | GRASP2 eQTL |
Gene expression of reporter ID 10023814496 in liver | 1.3×10-137 | 20084173 (PMID) | GRASP2 eQTL |
Gene expression of reporter ID 10023846331 in liver | 3.2×10-137 | 20084173 (PMID) | GRASP2 eQTL |
Total cholesterol | 3.2×10-137 | 20686565 (PMID) | GRASP2 nonQTL |
CELSR2 gene expression in human liver | 5×10-94 | 20686565 (PMID) | GRASP2 nonQTL |
SORT1 gene expression in liver tissue | 5.2×10-88 | 21602305 (PMID) | GRASP2 eQTL |
Gene expression of SORT1 in liver | 1.4×10-87 | 21637794 (PMID) | GRASP2 eQTL |
PSRC1 gene expression in liver tissue | 3.1×10-86 | 21602305 (PMID) | GRASP2 eQTL |
Gene expression of CELSR2 in Liver | 5×10-73 | 21378990 (PMID) | GRASP2 nonQTL |
CELSR2 gene expression in liver tissue | 6.3×10-68 | 21602305 (PMID) | GRASP2 eQTL |
Gene expression of PSRC1 in peripheral blood monocytes | 2.3×10-56 | 20502693 (PMID) | GRASP2 eQTL |
APOB assay lipoprotein fraction concentration | 1.8×10-53 | 19936222 (PMID) | GRASP2 nonQTL |
Lipid metabolism phenotypes | 2×10-53 | 19936222 (PMID) | GWAS Catalog via SNiPA |
Gene expression of PSRC1 in liver | 2.2×10-53 | 18462017 (PMID) | GRASP2 eQTL |
LDL cholesterol lipoprotein fraction concentration | 5×10-46 | 19936222 (PMID) | GRASP2 nonQTL |
APOB (apolipoprotein B) | 3.9×10-41 | 23100282 (PMID) | GRASP2 nonQTL |
cg09754932 (chr1:109820547) | 2.4×10-40 | 10.1101/033084 (DOI) | BIOS QTL cis-meQTLs |
APOB assay lipoprotein fraction concentration in fasting sample | 3.7×10-39 | 19936222 (PMID) | GRASP2 nonQTL |
PSRC1 transcript levels | 8.7×10-38 | 21606135 (PMID) | GRASP2 nonQTL |
LDL cholesterol in serum | 1.2×10-33 | 18262040 (PMID) | GRASP2 nonQTL |
LDL cholesterol lipoprotein fraction concentration in fasting sample | 1.2×10-32 | 19936222 (PMID) | GRASP2 nonQTL |
LDL cholesterol (female) | 3.4×10-31 | 22629316 (PMID) | GRASP2 nonQTL |
Gene expression of PSRC1 in blood | 7.3×10-31 | 21829388 (PMID) | GRASP2 eQTL |
Plasma progranulin levels | 1.7×10-30 | 21087763 (PMID) | GRASP2 nonQTL |
Progranulin levels | 2×10-30 | 21087763 (PMID) | GWAS Catalog via SNiPA |
LDL cholesterol total lipoprotein fraction concentration | 2.4×10-27 | 19936222 (PMID) | GRASP2 nonQTL |
Gene expression of PSRC1 in Blood | 1.1×10-26 | 21378990 (PMID) | GRASP2 nonQTL |
Coronary artery disease (CAD) | 4.7×10-26 | 23202125 (PMID) | GRASP2 nonQTL |
Coronary artery disease and myocardial infarction | 4.7×10-26 | 23202125 (PMID) | Supplemental file |
LDL cholesterol (male) | 6.3×10-25 | 22629316 (PMID) | GRASP2 nonQTL |
Gene expression of CELSR2 in liver | 3.1×10-24 | 18462017 (PMID) | GRASP2 eQTL |
SYPL2 gene expression in human liver | 1×10-23 | 20686565 (PMID) | GRASP2 nonQTL |
Lipoprotein-associated phospholipase A2 activity (Lp-PLA2) | 1.5×10-22 | 23118302 (PMID) | GRASP2 nonQTL |
Cardiovascular disease risk factors | 2×10-22 | 21943158 (PMID) | GWAS Catalog via SNiPA |
Lipoprotein-associated phospholipase A2 activity and mass | 2×10-22 | 23118302 (PMID) | GWAS Catalog via SNiPA |
Gene expression of PSRC1 in Monocytes | 7.7×10-21 | 21378990 (PMID) | GRASP2 nonQTL |
LDL cholesterol total lipoprotein fraction concentration in fasting sample | 2.2×10-20 | 19936222 (PMID) | GRASP2 nonQTL |
Coronary artery disease (CAD) age <=50 | 2.8×10-20 | 23202125 (PMID) | GRASP2 nonQTL |
Gene expression of PSRC1 in Macrophages | 4.8×10-20 | 21378990 (PMID) | GRASP2 nonQTL |
Metabolite levels | 2×10-19 | 21909109 (PMID) | GWAS Catalog via SNiPA |
VLDL cholesterol small lipoprotein fraction concentration | 6.3×10-19 | 19936222 (PMID) | GRASP2 nonQTL |
Coronary artery disease (CAD) (males) | 1.3×10-18 | 23202125 (PMID) | GRASP2 nonQTL |
Lp-PLA2 activity | 1.3×10-17 | 22003152 (PMID) | GRASP2 nonQTL |
Coronary artery disease or large artery stroke | 8×10-17 | 24262325 (PMID) | GWAS Catalog via SNiPA |
PSMA5 gene expression in human liver | 9×10-17 | 20686565 (PMID) | GRASP2 nonQTL |
"Gene expression of CELSR2 [transcript NM_001408, probe A_24_P182620] in liver" | 2×10-16 | 21637794 (PMID) | GRASP2 eQTL |
Coronary artery disease (CAD) with myocardial infarction (MI) | 2.2×10-16 | 23202125 (PMID) | GRASP2 nonQTL |
Metabolic syndrome domains (Atherogenic Dyslipidemia - PC1) | 8×10-16 | 22022282 (PMID) | GRASP2 nonQTL |
HDL cholesterol | 1.7×10-15 | 24097068 (PMID) | Supplemental file |
VLDL cholesterol small lipoprotein fraction concentration in fasting sample | 1.6×10-13 | 19936222 (PMID) | GRASP2 nonQTL |
Metabolic syndrome domains (Multivariate analysis) | 3.6×10-13 | 22022282 (PMID) | GRASP2 nonQTL |
LDL cholesterol (mmol/l) | 6.6×10-13 | 19060910 (PMID) | GRASP2 nonQTL |
Lipoproteins, ldl | 2.2×10-12 | pha002902 (dbGaP) | dbGaP via SNiPA |
Serum M-LDL-C/M-LDL-PL | 2.4×10-12 | 22286219 (PMID) | GRASP2 metabQTL |
LDL cholesterol exam 1 values | 6.2×10-12 | 19060906 (PMID) | GRASP2 nonQTL |
Myocardial infarction (MI) early age of onset | 7.9×10-12 | 19198609 (PMID) | GRASP2 nonQTL |
Coronary heart disease (CHD) | 8×10-12 | 21347282 (PMID) | GRASP2 nonQTL |
Myocardial infarction (early onset) | 8×10-12 | 19198609 (PMID) | GWAS Catalog via SNiPA |
Serum Gp/Tot-C | 8.9×10-12 | 22286219 (PMID) | GRASP2 metabQTL |
LDL cholesterol small lipoprotein fraction concentration | 9.2×10-12 | 19936222 (PMID) | GRASP2 nonQTL |
Serum L-LDL-FC | 6.9×10-11 | 22286219 (PMID) | GRASP2 metabQTL |
VLDL cholesterol total lipoprotein fraction concentration | 7.1×10-11 | 19936222 (PMID) | GRASP2 nonQTL |
Angiographic coronary artery disease (CAD) | 7.9×10-11 | 21239051 (PMID) | GRASP2 nonQTL |
Coronary Artery Disease | 8×10-11 | 21239051 (PMID) | GWAS Catalog via SNiPA |
Total cholesterol (exam 1) | 9.2×10-11 | 19060906 (PMID) | GRASP2 nonQTL |
Coronary heart disease | 3×10-10 | 21378990 (PMID) | GWAS Catalog via SNiPA |
Gene expression of PSRC1 in Subcutaneous adipose | 1.3×10-9 | 21378990 (PMID) | GRASP2 nonQTL |
LDL cholesterol small lipoprotein fraction concentration in fasting sample | 5×10-9 | 19936222 (PMID) | GRASP2 nonQTL |
cholesterol | 5×10-9 | 24816252 (PMID) | gwas.eu via SNiPA |
LDL cholesterol large lipoprotein fraction concentration | 6×10-9 | 19936222 (PMID) | GRASP2 nonQTL |
Coronary artery disease or ischemic stroke | 1×10-8 | 24262325 (PMID) | GWAS Catalog via SNiPA |
Coronary artery disease (CAD) with age of onset <=50 | 1.1×10-8 | 21378990 (PMID) | GRASP2 nonQTL |
LDL cholesterol change with statins | 3.7×10-8 | 20339536 (PMID) | GRASP2 nonQTL |
Height | 3.8×10-8 | 25282103 (PMID) | Supplemental file |
Myocardial infarction (MI) | 4.3×10-8 | 21378990 (PMID) | GRASP2 nonQTL |
Coronary artery disease (CAD) age >50 | 5×10-8 | 23202125 (PMID) | GRASP2 nonQTL |
LDL cholesterol (baseline) | 5×10-8 | 21977987 (PMID) | GRASP2 nonQTL |
Coronary heart disease (CHD) or coronary artery disease (CAD) | 6.5×10-8 | 22003152 (PMID) | GRASP2 nonQTL |
APOB (apolipoprotein B) response after 40mg daily simvastatin treatment | 2.4×10-7 | 23100282 (PMID) | GRASP2 nonQTL |
Gene expression of PSMA5 in liver | 2.4×10-7 | 18462017 (PMID) | GRASP2 eQTL |
Coronary artery disease (CAD) (men) | 5.7×10-7 | 21378990 (PMID) | GRASP2 nonQTL |
Gene expression of KIAA1324 in blood | 1.7×10-6 | 21829388 (PMID) | GRASP2 eQTL |
Total cholesterol to HDL cholesterol ratio | 1.8×10-6 | 19060906 (PMID) | GRASP2 nonQTL |
Gene expression of PSRC1 [probe 201896_s_at] in prefrontal cortex | 2.6×10-6 | 20351726 (PMID) | GRASP2 eQTL |
Gene expression of PSRC1 (probeID ILMN_1671843) in temporal cortex in Alzheimer's disease cases and controls | 3.3×10-6 | 22685416 (PMID) | GRASP2 eQTL |
Response to statin therapy | 4×10-6 | 20339536 (PMID) | GWAS Catalog via SNiPA |
Total cholesterol change with statins | 4.2×10-6 | 20339536 (PMID) | GRASP2 nonQTL |
Coronary artery disease (CAD) (women) | 4.7×10-6 | 21378990 (PMID) | GRASP2 nonQTL |
Coronary artery disease (CAD) with age of onset >50 | 5.5×10-6 | 21378990 (PMID) | GRASP2 nonQTL |
Gene expression of CELSR2 in peripheral blood monocytes | 7.6×10-6 | 20502693 (PMID) | GRASP2 eQTL |
Gene expression of SALL3 in blood | 1×10-5 | 21829388 (PMID) | GRASP2 eQTL |
Coronary artery disease (CAD) by angiography | 1.8×10-5 | 21378990 (PMID) | GRASP2 nonQTL |
Cholesterol | 2.7×10-5 | pha003078 (dbGaP) | dbGaP via SNiPA |
Coronary artery disease (CAD) (females) | 3.4×10-5 | 23202125 (PMID) | GRASP2 nonQTL |
Gene expression of PSRC1 (probeID ILMN_1801152) in temporal cortex in Alzheimer's disease cases and controls | 5.9×10-5 | 22685416 (PMID) | GRASP2 eQTL |
Lp-PLA2 mass | 7.1×10-5 | 22003152 (PMID) | GRASP2 nonQTL |
Gene expression of PSRC1 (probeID ILMN_2315964) in temporal cortex in Alzheimer's disease cases and controls | 8.1×10-5 | 22685416 (PMID) | GRASP2 eQTL |
LDL cholesterol response after 40mg daily simvastatin treatment | 9.5×10-5 | 23100282 (PMID) | GRASP2 nonQTL |
Coronary artery calcification (CAC) | 1.6×10-4 | 23727086 (PMID) | GRASP2 nonQTL |
Serum concentration of cholesterol | 2.4×10-4 | 21886157 (PMID) | GRASP2 metabQTL |
Serum concentration of butyrylcarnitine | 3×10-4 | 21886157 (PMID) | GRASP2 metabQTL |
Hip circumfence | 3.8×10-4 | 25673412 (PMID) | Supplemental file |
Trans-association of rs646776 replicates a strong immuno-assay based GWAS hit [PubMed] at the sortilin (SORT1) locus. Nguyen et al. [PubMed] state that "our understanding of the relationship between anti-inflammatory progranulin and its processing to the proinflammatory granulins remains limited" .. "in cultured macrophages, HDL blocked cleavage of progranulin into granulins and inhibited granulin-mediated inflammation" .. "Sortilin-deficient (Sort1 /) mice exhibited fivefold more circulating progranulin". In addition to the replicated GRN association we find here two weaker trans-associations of rs646776, with Catalase (CAT) and with Repulsive guidance molecule A (RGMA). The CAT association could not be replicated in QMDiab due to a lack of power, the RGMA association showed nominal association (p=0.022) with a similar trend (levels of all three proteins decrease with the minor allele of rs646776). Note that the SORT1 locus is also a major GWAS locus for total and LDL cholesterol, coronary artery disease. Although not replicated in QMDiab, our association data in KORA suggests a role for RGMA and CAT in the pathways that link cholesterol to coronary artery disease.
The information gathered here is a result of an attempt to keep track of all interesting information that we encountered while investigating these loci. Please bear in mind that the annotation given here is neither complete nor free of errors, and that all information provided here should be confirmed by additional literature research before being used as a basis for firm conclusions or further experiments.